News
Issued by Respira Therapeutics, not Gossamer Bio, Inc.
Respira Therapeutics Enters into Agreement with Gossamer Bio (Gossamer) Granting Gossamer Option to Acquire Respira from Samsara BioCapital
September 25, 2025 · View original source (PR Newswire)
It isn’t one of Gossamer Bio, Inc.’s news releases, so 6ix doesn’t show it on Gossamer Bio, Inc.’s page or send it as an alert.